Guest: Scott Newsome, DO, MSCS, FAAN

The complexity and heterogeneity of multiple sclerosis (MS) pathogenesis renders its clinical course and response to therapy highly variable, particularly among special populations. This includes patients considering pregnancy or minority patients. This necessitates optimal strategies to personalize therapy and monitor disease activity and progression in special populations. This educational activity will review cutting-edge research on the unique considerations for prognosis, monitoring, and treatment response in special populations of MS patients. Focused attention will be given to translating research into optimized therapeutic strategies tailored to patient-specific characteristics with the goal of slowing disease progression. A compelling case study will be presented to illustrate clinically relevant challenges in disease management. Fee Information & Refund/Cancellation Policy:There is no fee for this educational activity. To download the slide handouts for this presentation, please click here.